FDA Grants Approval for Tramadol Hydrochloride ANDA209404 by Macleods
The FDA has granted approval for ANDA209404, a supplemental application for Tramadol Hydrochloride by Macleods Pharmaceuticals.
Company
Pharmaceutical intelligence for Macleods Pharmaceuticals with 4 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No signals indexed for this entity yet.
No signals indexed for this entity yet.
No signals indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.